http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-041641-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d2c6d5ab13f90554250ed754835a819 |
| filingDate | 2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-041641-A1 |
| titleOfInvention | BIOPOLIMEROS DE FOSFOAMIDA POLICARBOXILICOS POLISUBSTITUIDOS, METHODS FOR ITS PRODUCTION AND USES OF COMPOSITIONS DERIVED FROM THESE |
| abstract | Polysubstituted polycarboxylic phosphoamide biopolymers (BFPP) are provided, which comprise polysaccharides and glycopolypeptides placed to a phospho-citrate structure; Phosphorylation of the biopolymers produces phosphorylated polysubstituted polycarboxylic phosphoamide (BFPPf) biopolymers that can be used as inflammatory response modulators, immunomodulators and / or biological response modifiers; The methods for the production of BFPPf in yeast are subjected to multiple chemical tensors, and uses of the compositions derived therefrom are provided. Claim 2: A biopolymer as in formula (1), characterized in that R1, R2, R3 and R4 are selected from the group comprising a hydrogen, a glycopolypeptide, a polysaccharide, a branched glycopolypeptide, and a branched polysaccharide, wherein the biopolymer It comprises more than four glycopolypeptides in total, or any combination of glycopolypeptides and / or totaling four, and wherein the biopolymer must contain at least one glycopolypeptide or at least a portion of polysaccharide. Claim 20: The method according to claim 19, further characterized in that the strain of yeast cells are of the Candida utilis species. Claim 21: The method according to claim 20, characterized in that the strain of yeast cells was deposited under ATCC number 9950. Claim 22: The method according to any one of claims 13, 14, 15, 16, 17, 18, 19, 20 or 21, further characterized in that the tensioner is a terpene, a pine tree resin, a starch, a natural oil or an animal DNA. Claim 30: The phosphorylated derivative according to any one of claims 4, 5, 6, 7, 8, 9, 10 or 11 for use in modulating the inflammatory and / or immune response in a patient in need of this. |
| priorityDate | 2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 13.